Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05563558
Title Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS) (PEAPOD_FOS)
Acronym PEAPOD_FOS
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Fundacion Oncosur
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.